2021 American Transplant Congress
Status of Kidney Allocation in Liver-kidney Transplants Before and After the UNOS/OPTN Policy
Department of Internal Medicine: Division of Transplant Nephrology, UCLA, Los Angeles, CA
*Purpose: On August 10, 2017 the United Network for Organ Sharing (UNOS) enacted policies 9.7 and 8.5G to establish medical criteria for simultaneous liver-kidney (SLK)…2021 American Transplant Congress
Single Incision Simultaneous Liver Kidney Transplantation: Outcomes and Feasibility
Virginia Commonwealth University, Richmond, VA
*Purpose: Simultaneous liver and kidney transplantation (SLK) is indicated in patients with concomitant end stage liver disease and severe chronic kidney disease or end stage…2021 American Transplant Congress
Rabbit Anti-thymocyte Globulin Induction is Not Associated with Improved Outcomes in Liver Transplant Recipients
Baylor University Medical Center, Dallas, TX
*Purpose: Controversy remains on the role of rabbit anti-thymocyte globulin (rATG) induction for calcineurin inhibitor (CNI) delay after liver transplantation (LT). We examined the effect…2021 American Transplant Congress
Clazakizumab for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: Phase 3 IMAGINE Study Design
*Purpose: Chronic active antibody-mediated rejection (CAMR) is a major cause of allograft loss with no approved drugs for its treatment. Currently, off-label regimens recommended by…2021 American Transplant Congress
Machine Perfusion of Kidney Grafts in Simultaneous Liver Kidney Transplantation: National Trends and Outcomes
*Purpose: In this study we analyze the SRTR liver data set to determine the trends in machine perfusion of kidney grafts prior to SLK and…2021 American Transplant Congress
HLA Allele Association with Recurrent Iga Nephropathy After Kidney Transplantation
Transplant, Washington University, Saint Louis, MO
*Purpose: IgA nephropathy is one of the most common glomerulonephritis after kidney transplantation. The association of IgA nephropathy recurrence with recipient HLA typing is not…2021 American Transplant Congress
Impact of Covid-19 in Transplant Care: Attitudes, Feeling and Behaviors of Liver, and Kidney Pre and Post Transplant Patients
Beth Israel Deaconess Medical Center, Boston, MA
*Purpose: The SARS-CoV-2(COVID-19) pandemic poses unique challenges for transplant patients, which may impact their attitudes, emotions and behaviors associated with transplant care. This study surveys…2021 American Transplant Congress
Defining the Characteristics and Graft Outcomes of Kidney Transplant Recipients with Elevated Plasma Oxalate Level Not Due to Primary Hyperoxaluria
*Purpose: Patients with elevated systemic oxalate burden due to enteric etiologies are at increased risk for calcium oxalate deposition causing ESRD. The objective of this…2021 American Transplant Congress
Comprehensive Utilization of HCV Viremic and Non-Viremic Donor Livers and Kidneys into HCV-negative Patients
Transplant Institute, Loma Linda University Health, San Bernardino, CA
*Purpose: We report our experience on virologic and graft outcomes of HCV-negative patients transplanted with HCV NAT+ (viremic) and HCV Ab+/NAT- (non-viremic) livers and kidneys…2021 American Transplant Congress
Development of Novel Multivariable Logistic Regression Model for Predicting Acute Kidney Injury After Liver Transplantation
Organ Transplant Center,, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
*Purpose: Acute kidney injury (AKI) is a common early complication after liver transplantation, but there are no related predictive tools or models at present. The…
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 24
- Next Page »